# Aemetis Faces Financing Risks Despite Q3 Gains

> Aemetis' Q3 results show improved operations but persistent financing risks keep it a sell.
- Title: Aemetis Faces Financing Risks Despite Q3 Gains · Seekingalpha
- Summary: Aemetis' Q3 results show improved operations but persistent financing risks keep it a sell.
- Keywords: aemetis, q3 results, financing risk, ebitda, india segment, rng growth, Seekingalpha
- Source: Seekingalpha — https://seekingalpha.com/article/4965909-aemetis-a-better-quarter-has-not-solved-the-financing-risk
- Published: 2026-11-10T18:19:41+00:00
- Read time: 1 min
- Topics: aemetis, q3 results, financing risk, ebitda, india segment, rng growth, money, business
## Q3 Results
Aemetis' Q3 adjusted EBITDA rose to $24.8M but $11M was a one-off credit recalculation.
## Cash Flow Shortfall
Cash flow from operations insufficient to cover $35.3M in investments.
## Financing Challenges
Heavy liabilities, expensive financing, and uncertain India segment performance outweigh RNG growth prospects.
## Key takeaway

Aemetis' Q3 adjusted EBITDA rose to $24.8M but heavy liabilities and uncertain India segment performance outweigh RNG growth prospects.